论文部分内容阅读
白细胞介素（IL-2）作为一种十分重要的细胞因子已逐渐在临床治疗中受到重视。我科于1996年10月～1997年8月以IL－2治疗晚期恶性肿瘤33例，取得较好疗效，现报告如下。资料与方法一、一般资料：全组对例，男18例，女15例，中位年龄58岁。其中29例经病理或细胞学确诊，4例肝癌经
Interleukin (IL-2) as a very important cytokine has gradually been paid attention to in clinical treatment. Our department treated 33 cases of advanced malignant tumors with IL-2 from October 1996 to August 1997, and achieved better results. The report is as follows. Data and Methods I. General information: The whole group included 18 males and 15 females, with a median age of 58 years. 29 cases were confirmed by pathology or cytology, 4 cases of liver cancer